What does a high Total Cholesterol to HDL ratio mean?

A high Total Cholesterol to HDL ratio indicates increased cardiovascular disease risk, with ratios above 5:1 considered concerning. This ratio helps predict heart disease better than total cholesterol alone, as it reflects the balance between harmful and protective cholesterol in your blood.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Total Cholesterol to HDL Ratio

The Total Cholesterol to HDL ratio is a powerful predictor of cardiovascular disease risk that provides more insight than looking at total cholesterol alone. This ratio compares your total cholesterol level to your HDL (high-density lipoprotein) cholesterol, often called "good" cholesterol. By examining this relationship, healthcare providers can better assess your risk of developing heart disease, stroke, and other cardiovascular conditions.

HDL cholesterol acts as a cardiovascular protector by removing excess cholesterol from your arteries and transporting it to your liver for disposal. When your total cholesterol is high relative to your HDL, it suggests an imbalance that could lead to cholesterol buildup in your arteries. This buildup, known as atherosclerosis, narrows blood vessels and increases the risk of heart attacks and strokes.

Understanding your cholesterol ratio is crucial for assessing cardiovascular health. Regular monitoring through comprehensive lipid testing can help you track changes and make informed decisions about your health.

Total Cholesterol to HDL Ratio Risk Categories

Risk categories based on American Heart Association guidelines. Individual risk assessment should consider additional factors.
Ratio RangeRisk LevelInterpretationRecommended Action
Below 3.5:1Below 3.5:1OptimalLow cardiovascular riskMaintain healthy lifestyle
3.5:1 - 5:13.5:1 - 5:1ModerateAverage cardiovascular riskImplement lifestyle changes
5:1 - 6:15:1 - 6:1HighElevated cardiovascular riskAggressive lifestyle changes, consider medical consultation
Above 6:1Above 6:1Very HighSignificantly elevated riskMedical intervention likely needed

Risk categories based on American Heart Association guidelines. Individual risk assessment should consider additional factors.

What the Numbers Mean

The Total Cholesterol to HDL ratio is calculated by dividing your total cholesterol by your HDL cholesterol. For example, if your total cholesterol is 200 mg/dL and your HDL is 50 mg/dL, your ratio would be 4:1. Understanding what different ratio levels mean can help you gauge your cardiovascular risk more accurately.

Optimal vs. High-Risk Ratios

According to the American Heart Association, an optimal Total Cholesterol to HDL ratio is below 3.5:1. Ratios between 3.5:1 and 5:1 indicate moderate risk, while ratios above 5:1 suggest high cardiovascular disease risk. Some research suggests that ratios above 6:1 double the average risk of heart disease in men.

It's important to note that these ratios should be interpreted alongside other cardiovascular risk factors, including blood pressure, family history, smoking status, and the presence of diabetes. Your healthcare provider will consider all these factors when assessing your overall cardiovascular health.

Gender Differences in Ratio Interpretation

Research shows that the Total Cholesterol to HDL ratio may have different implications for men and women. Women typically have higher HDL levels than men, especially before menopause, which often results in more favorable ratios. However, after menopause, women's HDL levels may decrease while LDL levels increase, potentially worsening their ratio.

Studies indicate that a ratio above 4.5:1 in women and above 5:1 in men significantly increases cardiovascular risk. These gender-specific differences highlight the importance of personalized risk assessment and monitoring.

Health Implications of a High Ratio

A high Total Cholesterol to HDL ratio carries significant health implications beyond just cardiovascular disease. When this ratio is elevated, it indicates that protective HDL cholesterol is too low relative to total cholesterol, creating an environment conducive to arterial damage and inflammation.

Cardiovascular Disease Risk

The primary concern with a high ratio is increased cardiovascular disease risk. Research from the Framingham Heart Study demonstrated that the Total Cholesterol to HDL ratio is a better predictor of coronary heart disease than total cholesterol alone. A high ratio indicates that cholesterol is more likely to accumulate in arterial walls, forming plaques that can rupture and cause heart attacks or strokes.

Additionally, a high ratio often correlates with other cardiovascular risk factors, including insulin resistance, metabolic syndrome, and chronic inflammation. These interconnected factors create a cascade of health issues that compound cardiovascular risk.

Metabolic Health Consequences

Beyond heart disease, a high Total Cholesterol to HDL ratio often signals broader metabolic dysfunction. People with high ratios frequently have insulin resistance, which can lead to Type 2 diabetes. The ratio also correlates with non-alcoholic fatty liver disease (NAFLD), as the liver plays a crucial role in cholesterol metabolism.

Research shows that individuals with high ratios often have elevated triglycerides, forming what's known as the "atherogenic lipid triad" - high triglycerides, low HDL, and small, dense LDL particles. This combination significantly increases the risk of cardiovascular events and metabolic complications.

Common Causes of an Elevated Ratio

Understanding what drives a high Total Cholesterol to HDL ratio can help you address the root causes rather than just treating the numbers. Both lifestyle factors and genetic predispositions play crucial roles in determining your cholesterol profile.

Dietary and Lifestyle Factors

Diet significantly impacts your cholesterol ratio. Consuming high amounts of saturated and trans fats can raise total cholesterol while simultaneously lowering HDL. Processed foods, fried foods, and baked goods often contain these harmful fats. Additionally, excessive sugar and refined carbohydrate intake can lower HDL levels and increase triglycerides, indirectly worsening your ratio.

Physical inactivity is another major contributor to poor cholesterol ratios. Regular exercise, particularly aerobic activity, can increase HDL levels by 5-10% while also helping to lower total cholesterol. Smoking dramatically lowers HDL levels - quitting can improve HDL by up to 10% within weeks. Excessive alcohol consumption and chronic stress also negatively impact cholesterol metabolism.

Medical Conditions and Medications

Several medical conditions can worsen your Total Cholesterol to HDL ratio. Diabetes and insulin resistance often lead to low HDL and high triglycerides. Hypothyroidism can increase total cholesterol levels, while conditions like metabolic syndrome combine multiple factors that adversely affect your ratio.

Certain medications can also impact your cholesterol profile. Beta-blockers, some diuretics, and corticosteroids may lower HDL levels. Anabolic steroids and some immunosuppressants can significantly worsen cholesterol ratios. If you're taking these medications, regular cholesterol monitoring becomes even more important.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Monitoring Your Ratio

Regular testing is essential for understanding and managing your Total Cholesterol to HDL ratio. The American Heart Association recommends that adults over 20 have their cholesterol checked every 4-6 years, though more frequent testing may be necessary if you have risk factors or are actively working to improve your levels.

A comprehensive lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. From these values, your Total Cholesterol to HDL ratio can be calculated. For the most accurate results, you should fast for 9-12 hours before testing, though some newer tests don't require fasting. Regular monitoring helps track your progress and adjust treatment strategies as needed.

Advanced Lipid Testing

While standard lipid panels provide valuable information, advanced testing can offer deeper insights into your cardiovascular risk. Tests for apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1) measure the proteins that carry cholesterol, potentially providing more accurate risk assessment than traditional cholesterol measurements alone.

Particle size testing can determine whether you have small, dense LDL particles (more harmful) or large, fluffy ones (less harmful). Lipoprotein(a) testing identifies genetic risk factors that standard panels miss. These advanced markers can be particularly helpful if you have a family history of heart disease or if your standard cholesterol numbers don't align with your overall risk profile.

Strategies to Improve Your Ratio

Improving your Total Cholesterol to HDL ratio requires a two-pronged approach: lowering total cholesterol while raising HDL levels. The good news is that many lifestyle interventions can accomplish both goals simultaneously.

Dietary Modifications

The Mediterranean diet has shown remarkable success in improving cholesterol ratios. This eating pattern emphasizes olive oil, nuts, fatty fish, whole grains, and abundant fruits and vegetables. Studies show it can increase HDL by 10% while lowering total cholesterol. Replacing saturated fats with monounsaturated fats from sources like avocados and olive oil is particularly effective.

Increasing soluble fiber intake from oats, beans, and psyllium can lower total cholesterol by 5-10%. Omega-3 fatty acids from fish or supplements can raise HDL while lowering triglycerides. Plant sterols and stanols, found in fortified foods or supplements, can reduce cholesterol absorption by up to 10%. Limiting refined sugars and processed foods helps prevent HDL suppression.

Exercise and Lifestyle Changes

Regular aerobic exercise is one of the most effective ways to improve your cholesterol ratio. Aim for at least 150 minutes of moderate-intensity exercise weekly. High-intensity interval training (HIIT) may be particularly effective at raising HDL levels. Resistance training also contributes to better cholesterol profiles when combined with aerobic exercise.

Weight loss, even modest amounts of 5-10% of body weight, can significantly improve your ratio. Quitting smoking can increase HDL by 15-20%. Moderate alcohol consumption (one drink daily for women, two for men) may raise HDL, though the risks often outweigh benefits. Stress management through meditation, yoga, or other relaxation techniques can also positively impact cholesterol metabolism.

When to Seek Medical Intervention

While lifestyle modifications form the foundation of cholesterol management, some individuals may need medical intervention to achieve optimal ratios. Generally, if your Total Cholesterol to HDL ratio remains above 5:1 despite three to six months of dedicated lifestyle changes, it's time to discuss medication options with your healthcare provider.

Statins remain the first-line medication for improving cholesterol ratios, as they can lower LDL by 30-50% while modestly raising HDL. Other options include ezetimibe, which blocks cholesterol absorption, and PCSK9 inhibitors for those with genetic conditions or statin intolerance. Fibrates and niacin specifically target HDL elevation but are used less frequently due to side effects. Your doctor will consider your overall cardiovascular risk, including family history, blood pressure, and other factors when recommending treatment.

The Path Forward: Taking Control of Your Cholesterol Ratio

A high Total Cholesterol to HDL ratio is a significant cardiovascular risk factor, but it's also a modifiable one. Understanding your numbers empowers you to take targeted action to improve your heart health. Whether through dietary changes, increased physical activity, or medical intervention when necessary, you have multiple tools to optimize your cholesterol profile.

Remember that improving your ratio is a gradual process that requires consistency and patience. Small, sustainable changes often yield better long-term results than drastic short-term measures. Regular monitoring helps you track progress and adjust your approach as needed. By taking proactive steps today, you're investing in your cardiovascular health for years to come.

References

  1. Millán, J., Pintó, X., Muñoz, A., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Lemieux, I., Lamarche, B., Couillard, C., et al. (2001). Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. Archives of Internal Medicine, 161(22), 2685-2692.[PubMed][DOI]
  3. Calling, S., Johansson, S. E., Wolff, M., et al. (2021). Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden. BMC Cardiovascular Disorders, 21(1), 163.[PubMed][DOI]
  4. Arsenault, B. J., Rana, J. S., Stroes, E. S., et al. (2009). Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology, 55(1), 35-41.[PubMed][DOI]
  5. Prospective Studies Collaboration. (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 370(9602), 1829-1839.[PubMed][DOI]
  6. Elshazly, M. B., Nicholls, S. J., Nissen, S. E., et al. (2016). Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events. American Journal of Cardiology, 118(5), 647-655.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Total Cholesterol to HDL ratio at home?

You can test your Total Cholesterol to HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including total cholesterol, HDL, LDL, and triglycerides, allowing you to calculate and track your ratio over time.

What is considered a healthy Total Cholesterol to HDL ratio?

A healthy Total Cholesterol to HDL ratio is below 3.5:1, with optimal levels being closer to 3:1. Ratios between 3.5:1 and 5:1 indicate moderate risk, while ratios above 5:1 suggest high cardiovascular disease risk.

How quickly can I improve my cholesterol ratio?

With consistent lifestyle changes, you may see improvements in your cholesterol ratio within 6-12 weeks. HDL levels typically respond more slowly than total cholesterol, so patience is important. Significant improvements often occur within 3-6 months of sustained healthy habits.

Can I have a high ratio even with normal total cholesterol?

Yes, you can have a high Total Cholesterol to HDL ratio even if your total cholesterol appears normal. This occurs when HDL levels are too low, which is why looking at the ratio provides better risk assessment than total cholesterol alone.

What foods most effectively improve the cholesterol ratio?

Foods rich in omega-3 fatty acids (salmon, walnuts), monounsaturated fats (olive oil, avocados), and soluble fiber (oats, beans) are most effective. These foods can simultaneously lower total cholesterol while raising HDL levels.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details